Neutral impactCorporate Action
Natco Pharma Limited — Record Date
NSE 1 hr ago·25 Sept 2026, 5:53 am
Natco PharmaNatco Pharma has announced that the record date for its upcoming rights issue will be October 1, 2026. This date is crucial for determining which shareholders are eligible to participate in the offer and receive the new shares. The company has filed this information with the stock exchanges to ensure transparency for all investors.
For investors, this announcement confirms that the rights issue process is officially underway. It marks a significant step forward for the company's capital raising plans. Shareholders holding shares on this specific date will be the only ones who can apply for the rights entitlements.
Investors should now look out for the detailed offer document, which will outline the ratio of new shares to be issued, the price, and the subscription period. Keeping an eye on these details will help you understand the dilution impact and decide whether to exercise your rights.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Natco Pharma (NATCOPHARM).
- Category: Corporate Action.
Why it matters
A routine update for Natco Pharma. Use the price and stock snapshot to gauge how the market is responding.
